CXCL9 and cancer: (39) observed an interaction between K17 and the heterogeneous ribonucleoprotein hnRNP K that plays a particularly prominent role in regulating the expression of the inflammatory chemokines CXCL9, CXCL10, and CXCL11 as a part of the growth-promoting signature in various types of cancers.